| Company/Division name | AGC Biologics |
| Parent company | Asahi Glass Company (AGC) Bioscience |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 280 |
| Year reshoring announced: | 2020 |
| Capital investment ($): | 100 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Boulder |
| State(s) reshored to: | CO |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biopharma |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Proximity to customers/market, Under-utilized capacity |
